Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald L Hamilton

Showing results (81-90 of 141) with videos related to

Pageof 15
Sort By:
The New England Journal of Medicine|February 8, 2002
Expression of p53 and prognosis in children with malignant gliomasIan F Pollack, Sydney D Finkelstein, Jeffrey Woods, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 9, 2004
Neuropathologic correlates of late-onset major depressionRobert A Sweet, Ronald L Hamilton, Meryl A Butters, et al.
Neurobiology of Disease|May 27, 2005
Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortexPurnima P Desai, Milos D Ikonomovic, Eric E Abrahamson, et al.
Neuro-Oncology|March 8, 2011
N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomideJiang-bo Tang, David Svilar, Ram N Trivedi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 27, 2003
The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid componentWilliam E Klunk, Yanming Wang, Guo-feng Huang, et al.
Journal of Neuropathology and Experimental Neurology|January 6, 2007
Expression of Nrf2 in neurodegenerative diseasesChenere P Ramsey, Charles A Glass, Marshall B Montgomery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2014
Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and nonbrainstem gliomasIan F Pollack, Regina I Jakacki, Lisa H Butterfield, et al.
Neuro-Oncology|March 18, 2016
Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomasIan F Pollack, Regina I Jakacki, Lisa H Butterfield, et al.
Journal of Neuro-Oncology|September 15, 2016
Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot studyIan F Pollack, Regina I Jakacki, Lisa H Butterfield, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 17, 2009
Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysisRichard A Armstrong, William Ellis, Ronald L Hamilton, et al.
Pageof 15

Showing results (81-90 of 141) with videos related to

Sort By:
Pageof 15
The New England Journal of Medicine|February 8, 2002
Expression of p53 and prognosis in children with malignant gliomasIan F Pollack, Sydney D Finkelstein, Jeffrey Woods, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 9, 2004
Neuropathologic correlates of late-onset major depressionRobert A Sweet, Ronald L Hamilton, Meryl A Butters, et al.
Neurobiology of Disease|May 27, 2005
Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortexPurnima P Desai, Milos D Ikonomovic, Eric E Abrahamson, et al.
Neuro-Oncology|March 8, 2011
N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomideJiang-bo Tang, David Svilar, Ram N Trivedi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 27, 2003
The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid componentWilliam E Klunk, Yanming Wang, Guo-feng Huang, et al.
Journal of Neuropathology and Experimental Neurology|January 6, 2007
Expression of Nrf2 in neurodegenerative diseasesChenere P Ramsey, Charles A Glass, Marshall B Montgomery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2014
Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and nonbrainstem gliomasIan F Pollack, Regina I Jakacki, Lisa H Butterfield, et al.
Neuro-Oncology|March 18, 2016
Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomasIan F Pollack, Regina I Jakacki, Lisa H Butterfield, et al.
Journal of Neuro-Oncology|September 15, 2016
Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot studyIan F Pollack, Regina I Jakacki, Lisa H Butterfield, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 17, 2009
Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysisRichard A Armstrong, William Ellis, Ronald L Hamilton, et al.
Pageof 15